Table 3.
Psychiatrist’s Attitudes Toward BDZs
| Do you believe … | Agree | Not Applicable |
|---|---|---|
| Q1 … that dose reduction of BDZs is difficult? | 78.1% (121/155) | 0% (0/155) |
| Q2 … that anxiolytics have efficacy for anxiety? | 69.7% (108/155) | 14.2% (22/155) |
| Q3 … that hypnotics have efficacy for insomnia? | 75.5% (117/155) | 14.2% (22/155) |
| Q4 … that anxiolytics have efficacy for pain? | 12.9% (20/155) | 38.1% (59/155) |
| Q5 … that anxiolytics have efficacy for depressive mood? | 51.6% (80/155) | 18.1% (28/155) |
| Q6 … that anxiolytics are necessary even with psychotherapy? | 52.3% (81/155) | 14.8% (23/155) |
| Q7 … that psychotherapy takes long time? | 93.5% (145/155) | 2.6% (4/155) |
| Q8 for patients … that psychotherapy is unsuitable for yourself? | 67.1% (104/155) | 0% (0/155) |
| Q8 for psychiatrists … that psychotherapy is unsuitable for this patient? | ||
| Q9 for patients … that the continued administration of BDZs should continue as long as you desire? | 72.9% (113/155) | 0.6% (1/155) |
| Q9 for psychiatrists … that the continued administration of BDZs is justified because of the patient’s desire? | ||
| Q10 for patients … that the continued administration of BDZs is justified as long as social functions (job/housekeeping/study) are maintained? | 74.8% (116/155) | 0.6% (1/155) |
| Q10 for psychiatrists … that the continued administration of BDZs is justified because the patient’s social functions are maintained? | ||
| Q11 for patients … that the continued administration of BDZs is justified as long as adverse effects are not observed? | 75.5% (117/155) | 0% (0/155) |
| Q11 for psychiatrists … that the continued administration of BDZs is justified because adverse effect have not been observed? | ||
| Q12 for patients … that the continued administration of BDZs is justified for 1 month? | 39.4% (61/155) | 7.1% (11/155) |
| Q12 for psychiatrists … that the continued administration of BDZs is justified for 1 month for this patient? | ||
| Q13 … that information about addiction is important? | 98.1% (152/155) | 0% (0/155) |
| Q14 … that BDZs increase falls? | 5.2% (8/155) | 1.3% (2/155) |
| Q15 … that BDZs lead to daytime drowsiness? | 18.1% (28/155) | 0.6% (1/155) |
| Q16 … that rapport breaks down without the administration of BDZs? | 41.3% (64/155) | 0% (0/155) |
| Q17 … that the dose of BDZs has increased since the initial administration? | 35.5% (55/155) | 1.9% (3/155) |
| Q18 for patients Do you not want to take BDZs on principle? | 65.8% (102/155) | 0% (0/155) |
| Q18 for psychiatrists Do you not want to prescribe BDZs to this patient on principle? |
Abbreviation: BDZs, benzodiazepines.